Abstract
Purpose: To evaluate the safety profile of a brimonidine extended release intravitreal implant, in normotensive rabbit eyes. Methods: Devices were made from hollow poly-l-lactic acid (PLA) tubes and contained hundred micrograms of brimonidine pamoate. Device was injected intravitreally in one eye of 12 New Zealand pigmented rabbits, whereas other eye was injected with a sham implant in masked fashion. Ocular examination was conducted at baseline and months 1, 3 and 6 including dilated fundus examination and electro-retinogram (ERG). Four rabbits were sacrificed at each time-point for retinal histology. ERG data were compared between groups and time-points using anova. Results: No complications were reported from either eye of any rabbits over a 6-month period. Photopic A wave was reduced in the control eye at 1 month compared with baseline (p < 0.01). There was no significant difference in other ERG parameters between the groups at different time-points. Gross retinal histology was normal at all time-points. Conclusion: Extended release intravitreal brimonidine device was found to be safe and in normotensive rabbit eyes. © 2012 The Authors. Acta Ophthalmologica.
Author supplied keywords
Cite
CITATION STYLE
Deokule, S. P., Baffi, J. Z., Guo, H., Nazzaro, M., & Kaneko, H. (2012). Evaluation of extended release brimonidine intravitreal device in normotensive rabbit eyes. Acta Ophthalmologica, 90(5). https://doi.org/10.1111/j.1755-3768.2012.02418.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.